ARTICLE | Clinical News
BHV-0223: Phase I data
February 29, 2016 8:00 AM UTC
A Phase I trial in 10 subjects showed that single and multiple doses of sublingual BHV-0223 led to faster absorption and higher peak concentrations and greater absorption of riluzole on a dose-normali...